We have treated Caki -2 human renal cell carcinoma in vivo using herpes simplex virus thymidine kinase ( HSV -tk ) gene therapy. Both stably transduced Caki -2 tumors, generated using retrovirus -mediated ex vivo HSV -tk gene transfer and direct intratumoral adenovirus -mediated HSV -tk gene transfer of wild type tumors, were tested. Similar treatments with LacZ containing retro -and adenoviruses were used as controls. The outcome was evaluated by imaging the tumors before and after the treatment with magnetic resonance imaging, and using histology, immunocytochemistry, and survival analysis. When implanted orthotopically into nude mouse kidneys, Caki -2 cells formed reproducible cystic papillary kidney carcinomas. In vivo magnetic resonance imaging provided an important tool for the evaluation of tumor growth. Transduction efficiency of wild -type tumors in vivo with adeno -LacZ was 22 14%. Significant tumor regression was achieved with direct intratumoral adeno -HSV -tk transduction followed by intraperitoneal ganciclovir ( GCV ) ( P < .001 ). Also, the treatment of stably transduced Caki -2 tumors with intraperitoneal GCV resulted in a significant treatment response in the HSV -tk group as compared to the LacZ group ( P < .009 ). Increased apoptosis and macrophage infiltrations, reduced proliferation, and degenerative changes were observed in the tumors treated with HSV -tk and GCV. Also, significant prolongation in survival was achieved with adeno -HSV -tk ± and GCV -treated mice as compared to the controls. It is concluded that adeno -HSV -tk gene therapy may be useful for the treatment of renal cell carcinoma in vivo. Cancer Gene Therapy ( 2001 ) 8, 529 ± 536
H uman renal cell carcinoma (RCC ) is a malignant tumor arising from tubular epithelial cells. It accounts for 85% of all kidney malignancies in adults. 1 Currently, the treatment of choice for primary tumors is radical nephrectomy or partial resection of kidney. Approximately one third of the patients has metastases at the time of diagnosis. Radio -and chemotherapy are of little value in the treatment of both primary tumors and metastases, but they are used for palliative reasons. Treatment strategies using immunotherapy ( interferons, interleukins ) have resulted in modest success. 2 Gene therapy offers a new possibility for the treatment of RCC. HSV-tk suicide gene transfer, combined with systemically administered ganciclovir (GCV ), is one of the most widely used gene therapy methods for cancer. 3 ± 5 In an earlier study, HSV-tk gene therapy for subcutaneously (s.c. ) grown human RCCs in nude mice 6 failed to demonstrate an antitumor effect.
We have studied HSV-tk treatment for human RCC in a nude mouse model, where Caki -2 cells were inoculated into renal subcapsule. 7 Human Caki-2 tumors have not been tested for HSV-tk therapy before. Both stably transduced Caki-2 cells and direct intratumoral adenovirus -mediated gene transfer to wild -type tumors were tested. It was found that HSV-tk gene therapy led to degenerative changes, increased apoptosis, and significant tumor regression.
MATERIALS AND METHODS

Generation of stably transduced cell lines
Human RCC cell line Caki-2 was obtained from the American Type Culture Collection (HTB -47; Rockville, MD, USA ). Cells were cultured in McCoy's 5A medium supplemented with 10% fetal bovine serum and 1Â PenStrep. All cell culture chemicals were obtained from Life Technologies (Paisley, Scotland). The cell line was tested to be free of mycoplasma and other microbiological contaminants. 7 Wild -type Caki -2 cells (Caki-2 /WT ) were stably transduced with replication -deficient HSV-tk 5 and LacZ ( titer 2Â10 6 cfu /mL ) 8 retroviruses using standard technol-ogy. 9, 10 Stably transduced cell lines were produced by geneticin selection: Caki -2 +HSV-tk ( Caki -2/ TK ) and Caki-2 +LacZ (Caki-2 /LacZ ). 9, 10 Stable Caki -2/ TK clones were tested with GCV ( Cymevene 1 500 mg; F. Hoffman-La Roche, Basel, Switzerland ) for the functionality of HSV-tk (drug concentrations 0, 0.01, 0.1, 1.0, 10, 100 g/ mL ) and for the bystander effect ( 0%, 1%, 5%, 10%, 20%, 30%, 50%, 100% of tk -positive cells; GCV concentration 10 g/ mL ). 5 The transduction of Caki -2 /LacZ clones was confirmed with X -gal staining (X -Gal B9146; Sigma, St. Louis, MO, USA ), and the clones were also tested for the cytotoxic effect. The best Caki -2 /TK and Caki -2/ LacZ clones were selected for the animal studies.
Animal model
For in vivo inoculation, the cells were harvested from subconfluent plates. After centrifugation, the cell pellet was suspended in 1 mL of serum -free culture medium, the number of cells was counted, the cells were recollected by centrifugation and resuspended in serum -free culture medium at the density of 33,500 cells / L. Cell suspension was kept on ice until inoculation. 7 Caki -2 /WT, Caki -2/ TK, and Caki-2/LacZ cells were prepared exactly according to the same protocol.
Sixty -four 6 -to 8-week -old Balb /cA -nu male nude mice ( M&B, Ry, Denmark ) were used. The mice were kept in a pathogen -free isolator unit. Food, water, and aspen wood chip bedding were autoclaved, and the mice received chow and water ad libitum. The mice were anesthesized with a s.c. injection of a mixture of fentanyl -fluanisone ( Hypnorm; Janssen -Cilag, Buckinghamshire, UK ) and midazolam (Dormicum 5 mg /mL; Roche, Espoo, Finland ), and the site of incision was swapped with 70% alcohol. The left kidney was exposed through a left flank incision and partially exteriorized. A small slit was made in the kidney capsule and 5Â10 5 cells suspended in 15 L of culture medium were inoculated into renal subcapsule. The kidney was then replaced into the body cavity, and the body wall and the skin incision were closed separately with sutures.
7 Figure 1 shows the study set -up in each group ( see below ).
Imaging
To confirm the presence of tumors and to evaluate the treatment outcome, in vivo magnetic resonance imaging ( MRI ) was performed using a 9.4-T vertical bore magnet ( Oxford Instruments, Oxford, UK ), equipped with actively shielded field gradients (Magnex Scientific, Abdington, UK ) interfaced to a SMIS console ( Surrey Medical Imaging Systems, Guildford, UK ). A single loop surface coil ( diameter 28 mm ) was used for signal transmission and reception. Mice were anesthesized with halothane (Halothane BP; Rhodia, Bristol, UK ) ( induction 2 ±3%, maintenance 1 ±2% ), fixed to a holder, and native multislice T 2 -weighted images were taken using parameters as follows: repetition time =2000 milliseconds, echo time = 35 milliseconds, field of view =40 mm, imaging matrix 256Â128 ( zero -filled to 256Â256), four averages and 18 ±26 slices with the slice thickness of 1 mm and 0.5 mm (no separation ) in horizontal and frontal orientations, respectively. Tumor volume measurements from MRI were done manually with Image Display ( Surrey Medical Imaging Systems ) software. 7 The volumes (mm 3 ) were calculated by measuring the area of the tumor in square millimeters in each slice, and multiplying the summation of the areas by the slice thickness.
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Preparation of tissue specimens for histological studies
The kidneys and tumor samples were excised and immersed in 4% paraformaldehyde for 4± 6 hours followed by overnight immersion in 15% sucrose. 12 The kidneys, liver, abdominal cavity, lungs, and brains were assessed macroscopically for metastases, and samples from these tissues and bones were harvested and fixed as described above for microscopic examination of metastatic growth. The specimens were embedded in paraffin, and tissue sections were analyzed with hematoxylin ±eosin, Ki-67 ( 08-0192; Zymed, South San Francisco, CA, USA ), macrophage (a rabbit antiserum, AIA31240; Accurate Chemical and Scientific, Westbury, NY, USA ), apoptosis ( Apoptag 1 Plus Fluorescein In Situ Apoptosis Detection Kit S7111; Intergen, Oxford, UK ), 7 and anti ±HSV-tk ( a rabbit polyclonal antibody, kindly provided by Dr. W.C. Summers, Yale University, New Haven ) 13 stainings. The gene transfer efficiency in vivo was studied with X -gal staining ( MBI Fermentas, Hanover, MD). Tumor samples and selected tissues from each animal were immersionfixed for 30 minutes with 4% paraformaldehyde /phosphate -buffered saline, rinsed for 30 minutes in 0.15 M sodium ± phosphate buffer, embedded in OCT compound ( Miles Scientific, Naperville, IL, USA ), and used for frozen sections. 10 Avidin ±biotin ±HRP ( Histostain -Plus; Zymed ), chromogens AEC (00 -1111; Zymed) and DAB ( 00-2020; Zymed ), and a FITC -conjugated goat antimouse IgG secondary antibody (F -2012; Sigma) were used for signal detection. Class -and species -matched irrelevant antibodies and incubations, where primary antibodies were omitted, were used as controls.
Gene therapy
Stably transduced tumors. The mice inoculated with Caki-2 /TK ( group V ) and Caki -2/ LacZ cells (group VI ) ( Table 1 and Figure 1A ) were imaged using MRI before and after the treatment to determine the tumor volumes. Both groups were treated with intraperitoneal ( i.p. ) GCV injections 50 mg /kg/ day divided into two doses for 14 days. After the treatment and MRI, mice were sacrificed and samples were harvested for histology.
Wild -type tumors. After renal subcapsule inoculation of wild -type Caki -2 cells, MRI was performed 4 weeks later to verify the presence and volume of tumors. The mice were randomly divided (Table 1 ) into a treatment group, which received adeno -HSV-tk gene transfer and GCV injections ( group I) ( Fig 1B ) ; a control group, which received adeno -HSV-tk gene transfer and 0.9% NaCl solution injections ( group II ) ( Fig 1B ) ; a wild -type group, which did not receive adeno -HSV-tk gene transfer and was used entirely for the survival study (group III ); and a LacZ group, which received adeno -LacZ marker gene transfer and was used for transduction efficiency and survival studies (group IV ) (Fig 1C) .
For the gene transfer, left kidney was exposed and the tumor was identified using an operating microscope. 7 Fifteen microliters of HSV-tk adenovirus 14 ( titer 2Â10 10 pfu /mL ) (groups I and II ) and 15 L of LacZ adenovirus 14 ( titer 2Â10 10 pfu / mL ) (group IV ) were injected into the tumor tissue using a 25 -L Hamilton Microliter 2 syringe ( RN 1702; Hamilton Bonaduz, Bonaduz, Switzerland ) and a 27-gauge needle ( RN 207427 /00; Hamilton Bonaduz ). A drop of Tisseel 1 Duo Quick tissue glue ( Immuno, Wien, Austria ) was applied on the injection site before withdrawing the needle to prevent leakage of the virus. Group I ( Fig 1B ) received i.p. GCV injections 50 mg /kg /day and Table 1 . Study Groups for HSV -tk Gene Therapy of Human RCC in Nude Mice group II (Fig 1B ) i.p. 0.9% NaCl solution injections ( equal volumes) for 14 days twice a day beginning on the fifth day posttransduction. MRI was performed again for groups I and II after the treatment; randomly selected mice from both groups were used for the survival study, and the rest were sacrificed ( Fig 1B ) . Six mice from group IV ( Fig 1C ) were sacrificed on the third, seventh, and 14th day posttransduction for the evaluation of the transduction efficiency using X -gal staining. 10 Autopsy was performed and histological samples were harvested at the time of death.
Statistical methods
Cavalier's method 11 was used for the calculation of tumor volumes from MRI. Relative volumes (pretreatment / posttreatment ratio ) were used. The measurements were carried out independently by two observers ( Pulkkanen and Tyynela ), and the average was used. Mann -Whitney U test was used for the statistical analysis of the treatment results, and Kaplan -Meier plots and log rank test for the analysis of survival data. Values are means SD.
RESULTS
In vitro studies
Retroviral HSV-tk and LacZ marker gene transductions of Caki-2 wild -type cells ( Caki -2 /WT ) produced several stable clones (data not shown). Caki-2 /TK ( Caki -2 +HSV-tk ) clones were tested for their susceptibility to GCV. Dosedependent decrease in the number of cells was observed in the tk -positive clones as compared to Caki-2/WT and Caki -2 /LacZ ( Caki -2 +LacZ ) cells confirming the presence of the cytotoxic effect ( Fig 2) . A modest bystander effect was also observed: 5% tk -positive cells were enough to result in a 60% growth arrest, but higher percentages of tk cells did not lead to any significant improvement (data not shown). The growth properties of the clones selected for inoculation were normal as compared to wild -type cells ( data not shown ).
Stably transduced tumors
Primary tumors produced by Caki-2 /TK ( group V ) and Caki-2 /LacZ (group VI ) ( see Table 1 and Figure 1A for the study group set -up ) cell inoculations were typical papillary RCCs. Their histological appearance did not differ from Caki-2/WT tumors 7 ( Fig 3A ) . Cysts comprised 1 /3± 2 /3 of the tumor volume. The nuclear grading of the tumors varied between II and III according to I± IV scale of Fuhrman et al. 15 The response to the i.p. GCV injections was evaluated by histology and MRI. Total regression of the tumors in group V did not occur, but significant antitumor response was observed ( Tables 1 and 2 ). The relative tumor volumes in groups V and VI were 0.58 0.19 and 2.40 1.60, respectively, measured from MRI ( P <.009). The histology of the tumors in group V showed degenerative changes in the majority of carcinoma cells: strongly reduced nuclear basophilia, vague or vanished cytoplasm and nuclear borders, and loss of nucleolei (Fig 3B ) , whereas these changes were absent in group VI (Fig 3C ) . Ki -67 staining showed 2.1 2.0% and 9.5 4.7% proliferation, and apoptosis rate was < 1% and <2% in groups V and VI, respectively ( data not shown ). The presence of HSV-tk was detected in group V residual tumors by anti ± HSV-tk immunostaining ( data not shown ).
Adenovirus gene transfer
Transduction efficiency. X -gal staining of the in vivo adenoLacZ transduced wild -type tumors (group IV ) showed 22 14% transduction efficiency (Fig. 4A ± B ) . No marked difference was detected in the amount of X -gal staining at 3 and 7 days time points, but at 14 days time point, the transduction efficiency had declined to < 1% (data not shown). X -gal staining was quite evenly distributed throughout the tumors, and it was also present in the cyst contents, indicating the presence of -galactosidase protein derived from tumor cells (Fig 4A ) . No positive X -gal staining was observed in the nontransfected control samples ( Fig 4C ) . Liver, spleen, lungs, and testis were harvested from the marker gene ±transduced mice. A few X -gal ± positive nuclei were detected in liver and spleen capsules, whereas no signal was found in other tissues (data not shown). ( Tables 1 and 2 ) were 1.0 0.85 and 3.46 2.63, respectively, measured from MRI (Fig 5A ± H) (P < .001). The grading of the tumors was III ± IV. 15 Few tumors in group I did not respond to the treatment. In contrast, all tumors in control group II progressed aggressively in spite of the identical intratumoral transduction. The histology of the tumors in group I, observed after the treatment period, showed similar degenerative changes ( Fig  3D ) that were observed in stably transduced tumors. Degeneration was not detected in the control group II tumors (Fig 3E ) . The proliferation indices in Ki -67 stainings were 11.2 2.5% in group I and 17.0 3.7% in group II ( Fig  3F ) . Apoptosis indices varied from 3% to 5% and from 1% to 2% in groups I ( Fig 3G ) and II ( Fig 3H ) , respectively. The number of macrophages was increased in both groups ( Fig  3I ±J ) as compared to wild -type tumors. Nontumoral kidney parenchyma appeared histologically normal.
Survival
Survival of mice in the study groups is presented in Figure 6 . The mean survival time of mice in group I (n =10 ) was 30 4, in group II ( n= 5) 26 4, in group III (n =16) 253, and in group IV (n = 6) 24 5 weeks. Healthy nude mice usually have a lifespan of 34 ± 52 weeks. 7, 16 Significant difference was found between groups I and III (P < .02), and I and IV ( P <.03 ). Difference between groups I and II did not reach statistical significance (P < .096 ). The mean tumor volumes in groups II, III, and IV at the time of death were 7.0 -, 6.9 -and 19.3-fold as compared with group I, respectively.
DISCUSSION
As far as we know, this is the first study where orthotopic human RCC has been treated with HSV-tk gene therapy. Previously, HSV-tk gene therapy did not demonstrate an antitumor effect for s.c. grown human RCCs in nude mice in vivo. 6 However, no gap junctions 7 were detected in the cell lines that were used in that study, which excludes benefits of the bystander effect of the HSV-tk therapy. Also, the ectopic tumor growth site might have affected the outcome because vascularization, fibrous encapsulation, and degree of necrosis in s.c. implanted renal tumors have been found to deviate from the orthotopic models. 7, 17, 18 We achieved a significant regression of wild -type papillary kidney carcinomas using intratumoral adeno -HSV-tk delivery followed by i.p. GCV (group I). The results were evident in MRI, and were supported by degenerative changes in histology, with concomitantly increased apoptosis and reduced proliferation rate. It is unlikely that cystic tumor structure could explain the results because no regression of tumors was found in controls (group II ), and histology showed intact but residual and degenerated structures in group I tumors. Also, the cyst structures were intact in adeno -LacZ± transduced controls (group IV ).
However, some tumors in group I progressed in spite of the treatment. The transduction efficiency is probably the critical issue. This is supported by the adeno -LacZ marker gene study, where in a few particular cases overall transduction efficiency was low. Thus, better gene delivery methods need to be developed to improve the treatment effect. Furthermore, cotransduction of the wild -type tumors with connexin gene to boost the expression of gap junctions 7 and with other compounds, which could enhance the bystander effect 19 and cytotoxicity against the tumor along with HSV-tk gene transfer, might improve the treatment effect. The exact mechanism of the bystander effect is not known, but it is assumed that gap junctions in cell -to -cell contacts allow the transfer of cytotoxic molecules from HSV-tk ± transduced tumor cells to the wild -type tumor cells, thus contributing to cell death. 5 On the other hand, the lack of fully competent immune system, particularly the absence of T cells, may diminish the tumor-killing potential of the bystander effect in nude mice. 19 According to the in vivo marker gene study of the wild -type tumors, the duration of adenovirus -mediated intratumoral gene transfer effect does not exceed 2 weeks. Repeated gene transfer 10 days after the first transduction might improve the treatment outcome, but this would require a reoperation and extension in GCV medication. An attractive observation is the feasibility and efficacy of intratumoral transduction of predominantly cystic tumors. It may have clinical relevance when seeking methods to combine cancer gene therapy with chemo -or radiosensitization.
It is concluded that significant tumor regression can be achieved in human RCC using HSV-tk gene therapy and systemic GCV medication. However, improvement in the gene transfer efficiency is needed before full potential of gene therapy can be achieved. 
